These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20401358)

  • 1. Mandibular function is severely impaired in systemic sclerosis patients.
    Ferreira EL; Christmann RB; Borba EF; Borges CT; Siqueira JT; Bonfa E
    J Orofac Pain; 2010; 24(2):197-202. PubMed ID: 20401358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study.
    Nacci F; Righi A; Conforti ML; Miniati I; Fiori G; Martinovic D; Melchiorre D; Sapir T; Blank M; Shoenfeld Y; Pignone AM; Cerinic MM
    Ann Rheum Dis; 2007 Jul; 66(7):977-9. PubMed ID: 17344244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis.
    Bezante GP; Rollando D; Sessarego M; Panico N; Setti M; Filaci G; Molinari G; Balbi M; Cutolo M; Barsotti A; Indiveri F; Ghio M
    J Rheumatol; 2007 Dec; 34(12):2431-7. PubMed ID: 17985401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
    Hanitsch LG; Burmester GR; Witt C; Hunzelmann N; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Müller-Ladner U; Schulze-Lohoff E; Becker M; Sunderkoetter C; ; Riemekasten G
    Rheumatology (Oxford); 2009 Jan; 48(1):70-3. PubMed ID: 19056798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
    Hamaguchi Y; Fujimoto M; Matsushita T; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairment.
    Rollando D; Bezante GP; Sulli A; Balbi M; Panico N; Pizzorni C; Negrini S; Brunelli C; Barsotti A; Cutolo M; Indiveri F; Ghio M
    J Rheumatol; 2010 Jun; 37(6):1168-73. PubMed ID: 20436078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis.
    Sandqvist G; Hesselstrand R; Eberhardt K
    Scand J Rheumatol; 2009; 38(4):304-10. PubMed ID: 19296402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum pentraxin 3 in patients with systemic sclerosis.
    Iwata Y; Yoshizaki A; Ogawa F; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 May; 36(5):976-83. PubMed ID: 19273457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Komura K; Yanaba K; Hayakawa I; Matsushita T; Takehara K
    Rheumatology (Oxford); 2004 Oct; 43(10):1261-6. PubMed ID: 15266059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD; Medsger TA
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular late potentials in systemic sclerosis: relationship with skin involvement.
    Paradiso M; Di Franco M; Musca A; Basili S; Riccieri V; Paoletti V; De Matteis A; Mammarella A
    J Rheumatol; 2002 Jul; 29(7):1388-92. PubMed ID: 12136893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
    Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
    Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin R; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold J
    Arthritis Rheum; 1999 Nov; 42(11):2372-80. PubMed ID: 10555033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptoms and signs of temporomandibular disorders in individuals with chronic whiplash-associated disorders.
    Klobas L; Tegelberg A; Axelsson S
    Swed Dent J; 2004; 28(1):29-36. PubMed ID: 15129603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
    Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
    J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin involvement in scleroderma--where histological and clinical scores meet.
    Verrecchia F; Laboureau J; Verola O; Roos N; Porcher R; Bruneval P; Ertault M; Tiev K; Michel L; Mauviel A; Farge D
    Rheumatology (Oxford); 2007 May; 46(5):833-41. PubMed ID: 17255134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis.
    Tomita H; Ogawa F; Hara T; Yanaba K; Iwata Y; Muroi E; Yoshizaki A; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2010 Apr; 37(4):787-91. PubMed ID: 20156945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis.
    Timár O; Soltész P; Szamosi S; Dér H; Szántó S; Szekanecz Z; Szücs G
    J Rheumatol; 2008 Jul; 35(7):1329-33. PubMed ID: 18484693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.